IPEC and FDA work on screening library of pharma excipients

Published: 21-Apr-2011

The library will assist the FDA in surveillance of raw materials


IPEC’s Excipient Qualification Committee members have agreed to assist the Division of Pharmaceutical Analysis (DPA) within the US FDA’s Centre for Drug Evaluation and Research to develop a comprehensive library of pharmaceutical excipient samples to help FDA develop its rapid screening capability.

The purpose will be to assist the FDA in surveillance of raw materials and finished products through rapid screening techniques to better identify materials in need of more in-depth analysis – in order to prevent counterfeit, contaminated and mislabelled substances from entering the market and causing harm.

The subcommittee is to be headed by Dr Philip Merrell, technical marketing manager of Jost Chemical Company, and Dr Buhse, Director of the FDA Division of Pharmaceutical Analysis (DPA) both of which are based in St Louis, Missouri.

For details visit ipecamericas.org

You may also like